Affiliation:
1. Okayama University, Japan
2. Hubei University, China & Okayama University, Japan
3. Liaoning Normal University, China & Okayama University, Japan
4. Graduate School of Natural Science and Technology, Okayama University, Japan
Abstract
Alzheimer's disease, a common form of dementia, is a type of neurodegenerative disease that affects more than 30% of the population older than 85. Clinically, it is characterized as memory loss and cognitive decline. Pathologically, its symptoms include cerebral atrophy, amyloid plaques and NFTs. Generally, the life expectancy is no more than nine years after the definite diagnosis, and life expectancy exceeds 14 years in only 3% of patients. Presently, there is no effective treatment to stop the process; the only measures we can take are to ease or improve symptoms temporarily. Therefore, it is necessary to diagnosis the disease in the early stage, such as through imaging detection via CT, MRI, PET and MSR, or prediction before the disease (genetic examination). However, literature data have supported the notion that Alzheimer's disease patients show cognitive reserve abilities to some degree. In the future, research perspectives may focus on the cognitive training paradigms in compensatory and restorative strategies.
Reference48 articles.
1. Alzheimer’s Association. (2011). 2011 Alzheimer's disease facts and figures. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 7, 208.
2. American Psychiatric Association. (2000). Diagnostic criteria from dsM-iV-tr. American Psychiatric Pub.
3. Utilizing compensatory task conditions for episodic memory in Alzheimer's disease
4. Hippocampal sulcus width and cavities: Comparison between patients with Alzheimer disease and nondemented elderly subjects.;A.Bastos-Leite;American Journal of Neuroradiology,2006
5. Cognitive Rehabilitation for Schizophrenia: Problems, Prospects, and Strategies